... , . , . , - , , , , , . ...

... , : . , , . . ...

... - . () ...

... , .. ...

... http://www. HYPERLINK "http://vak.ed.gov.ru/" vak.ed.gov.ru () HYPERLINK "http://www.google.com/url?q=http%3A%2F%2Fwww.kpfu.ru&sa=D&sntz=1&usg=AF QjCNEEM2nIOfsqG6EgGxOS4jvv_0gsHQ" \t "_blank" www.kpfu.ru . 9 2013 . ...

... . , . . . . , , ...

... 19 2013 . ______________________ .. ...

... 2Y12-, . 100 , ~15%, ~30% (Patrono C, et al., 2005, Antithrombotic Trialists Collaboration, 2002). - , - 2Y12 (Van de Werf ...

... 11 2013 . , , .. ...

... , . 80% , , . , ...

... .. . . ...

... . M HYPERLINK "http://www.rferat/" www.rferat vak @ mon.dov. ...

... .. . , - , - , , . ...

... Ѡ - . 21 2013 . http: // vak.ed.gov.ru ...

... 50-80%. , , 50-60 /. , . , , . . ...

... . , . , . , () , ?-. , ...

... .. ., 2004). 40 ( .. ., 2005). . , (PADAM) (Bremner W.J. et al., 1983; Gray A. et al., 1991). - - ( .., 1973; Vermuelen A. et al., 1998; .., .., 2003; .., .., 2004), ...

... , . . . , 68 72% ( .. ., 2009; .. ., 2012; .., 2012; Don M. et al., 2010). ...

... , , . . , , . , , , , . , ...

... 1. , . 1991 ., , , . ...